Lung cancer histologies associated with emphysema on computed tomography

Lung Cancer

Volumn 76, Issue 1, 2012, Pages 61-66

  Smith, Benjamin M ^a   Schwartzman, Kevin ^a   Kovacina, Bojan ^b   Taylor, Jana ^b   Kasymjanova, Goulnar ^c   Brandao, Guilherme ^d   Agulnik, Jason S ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Computed tomography; Emphysema; Histology; Lung cancer; Squamous cell carcinoma

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EMPHYSEMA; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SEX DIFFERENCE; SMALL CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RADIOGRAPHY, THORACIC; RISK FACTORS; SMALL CELL LUNG CARCINOMA; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858009287     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.09.003     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. WHO Cancer WHO fact sheet 2009, World Health Organization. February 2009 (Ed.).
3. de Torres J.P., Bastarrika G., Wisnivesky J.P., Alcaide A.B., Campo A., Seijo L.M., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007, 132:1932-1938.
4. Wilson D.O., Weissfeld J.L., Balkan A., Schragin J.G., Fuhrman C.R., Fisher S.N., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008, 178:738-744.
5. Maldonado F., Bartholmai B.J., Swensen S.J., Midthun D.E., Decker P.A., Jett J.R. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010, 138:1295-1302.
6. Li Y., Swensen S.J., Karabekmez L.G., Marks R.S., Stoddard S.M., Jiang R., et al. Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila) 2011, 4:43-50.
7. Travis W.D., World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology Pathology and genetics of tumours of the lung, pleura, thymus, and heart 2004, IARC Press, Lyon.
8. Papi A., Casoni G., Caramori G., Guzzinati I., Boschetto P., Ravenna F., et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004, 59:679-681.
9. Bergin C., Müller N., Nichols D.M., Lillington G., Hogg J.C., Mullen B., et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986, 133:541-546.
10. Gelb A.F., Hogg J.C., Müller N.L., Schein M.J., Kuei J., Tashkin D.P., et al. Contribution of emphysema and small airways in COPD. Chest 1996, 109:353-359.
11. Smith B. The relationship between emphysema on CT scan and lung cancer. Chest 2011, 139:1259.
12. Wilson D.O., Leader J.K., Fuhrman C.R., Reilly J.J., Sciurba F.C., Weissfeld J.L., et al. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh Lung Screening Study. J Thorac Oncol 2011, 6:1200-1205.
13. Kasymjanova G., Kreisman H., Correa J.A., Dajczman E., Small D. Does granulocyte colony-stimulating factor affect survival in patients with advanced non-small cell lung cancer?. J Thorac Oncol 2006, 1:564-570.
14. Cohen V., Agulnik J.S., Jarry J., Batist G., Small D., Kreisman H., et al. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer. Cancer 2006, 107:2858-2865.
15. Tagalakis V., Levi D., Agulnik J.S., Cohen V., Kasymjanova G., Small D. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol 2007, 2:729-734.
16. Gagnon B., Abrahamowicz M., Xiao Y., Beauchamp M.E., MacDonald N., Kasymjanova G., et al. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer 2010, 102:1113-1122.
17. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
18. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001, 345:1075-1083.
19. Janssen-Heijnen M.L., Schipper R.M., Razenberg P.P., Crommelin M.A., Coebergh J.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998, 21:105-113.
20. Stoller J.K., Aboussouan L.S. Alpha1-antitrypsin deficiency. Lancet 2005, 365:2225-2236.
21. Topic A.S., Jelic-Ivanovic Z.D., Spasojevic-Kalimanovska V.V., Spasic S.M. Association of moderate alpha-1 antitrypsin deficiency with lung cancer in the Serbian population. Arch Med Res 2006, 37:866-870.
22. Yang P., Wentzlaff K.A., Katzmann J.A., Marks R.S., Allen M.S., Lesnick T.G., et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999, 8:461-465.
23. Yang P., Sun Z., Krowka M.J., Aubry M.C., Bamlet W.R., Wampfler J.A., et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008, 168:1097-1103.
24. Sun Z., Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol 2004, 5:182-190.
25. Topic A., Ljujic M., Nikolic A., Petrovic-Stanojevic N., Dopudja-Pantic V., Mitic-Milikic M., et al. Alpha-1-antitrypsin phenotypes and neutrophil elastase gene promoter polymorphisms in lung cancer. Pathol Oncol Res 2011, 17:75-80.
26. Abboud R.T., Vimalanathan S. Pathogenesis of COPD, part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 2008, 12:361-367.